← FDA DRUG APPROVALS

FDA ANDA · ANDA085365

ACETAMINOPHEN AND CODEINE PHOSPHATE

Sponsor: KV PHARM

APPLICATION
ANDA085365
TYPE
ANDA
ORIGINAL APPROVAL
1977-08-23
LATEST ACTION
1996-12-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ACETAMINOPHEN AND CODEINE PHOSPHATEDiscontinued
ACETAMINOPHEN 300MG, CODEINE PHOSPHATE 60MG · TABLET · ORAL

Approval history

1996-12-12Labeling · Supplement 31AP
1991-03-22Labeling · Supplement 35AP
1988-05-04Labeling · Supplement 30AP
1977-08-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →